Drugs / ferrostrane
last change Oct 2024 re-read 9 days ago

ferrostrane

Developed for
craniosynostosis
Investigated by
University Hospital, Montpellier

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03231085 Oct 2017 → Apr 2024 craniosynostosis University Hospital, Montpellier Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ferrostrane ClinicalTrials.gov intervention name — accepted as the source's own label NCT03231085 ↗